Preliminary Program
Download PDF Version of the Program 
WEDNESDAY (24.5.2017)
13.00
Welcome and Registration
14.30
Welcome Authorities
Armando D’Angelo, Massimo Franchini & Franco Piovella
15.00 - 19:00
Opening Session
Chairmen and Discussants: Giovanni De Gaetano (Pozzilli, Italy) and Anna Falanga (Bergamo, Italy)
Marina Camera (Milano, Italy)
Management of patients on anti-platelet drugs in the perioperative setting
Marco Cattaneo (Milano, Italy)
Continuously 5-HT2A receptor signaling induced by serotonin is required for full platelet activation potential
Luigi De Marco (Aviano, Italy)
Neutrophil activation in inflammatory diseases? Bet on NETs!
Norma Maugeri (Milano, Italy)
Coagulation factors and risk of diseases: results from the Moli-sani and EPICOR studies
Licia Iacoviello (Pozzilli & Varese, Italy)
Homocysteine: still alive?
Giovanni Davì (Chieti, Italy)
Nox2 e atherothrombosis: insight from chronic granulomatous disease
Francesco Violi (Roma, Italy)
Mantua: Art, Architecture and History in one of the Capitals of the Italian Renaissance
Lorenzo Bonoldi (Mantova, Italy)
THURSDAY (25.5.2017)
9.00 - 13:00
Basic and Clinical I
Chairmen and Discussants: Antonio Girolami (Padova, Italy) and Gualtiero Palareti (Bologna, Italy)
Factor X generation and factor VIIa-Antithrombin complex levels in CAD patients
Francesco Bernardi (Ferrara, Italy)
Raimondo De Cristofaro (Roma, Italy)
Histone involvement in disease progression
Charles T. Esmon (Oklahoma City, USA)
Making diagnosis of deep vein thrombosis easier: the Palladio study
Walter Ageno (Varese, Italy)
Catheter-directed thrombolysis for DVT (CaVenT): incidence of psot-thrombotic syndrome after 5 years of follow up
P.M. Sandset (Oslo, Norway)
Chairmen and Discussants: Roberto Santi (Alessandria, Italy), Daniela Poli (Firenze, Italy)
Genotype-guided dosing of AVK drugs
Vittorio Pengo (Padova, Italy)
DOACs for VTE treatment in cancer patients
Giancarlo Agnelli (Perugia, Italy)
Network meta-analysis for the comparison of DOACs in venous thromboembolism
Alexander Cohen (London, UK)
Management strategies for oral anticoagulant-related major bleeding events
Sam Schulman (Hamilton, Canada)
Extended non-vitamin K antagonist oral anticoagulation for prevention of recurrent VTE
Franco Piovella (Pavia, Italy)
Follow-up of patients on DOACs
Sophie Testa (Cremona, Italy)
FRIDAY (26.5.2017)
9.30 - 13:30
Basic and Clinical II
Chairmen and Discussants: Naomi Esmon (Oklahoma City, USA) and Rossella Marcucci (Firenze, Italy)
Alireza Rezaie (Oklahoma City, USA)
Indoleamine 2,3-dioxygenase 1, Treg function and haemophilia
Davide Matino (Perugia, Italy)
Thrombosis in hematological malignancies
Benjamin Brenner (Haifa, Israel)
Family history and VTE risk
Maurizio Margaglione (Foggia, Italy)
Anticoagulation and hormone therapy
Ida Martinelli (Milano, Italy)
Acute stroke and atrial fibrillation: findings from the RAF study
Cecilia Becattini (Perugia,Italy)
14:30 - 18:30
Inherited and Acquired Bleeding Disorders
Chairmen and Discussant: Marina Camera (Milano, Italy) and Massimo Franchini (Mantova, Italy)
Bleeding risk of inherited platelet disorders
Paolo Gresele (Perugia, Italy)
Hemophilia A and B: which is worse?
Giancarlo Castaman (Firenze, Italy
Caplacizumab for acquired thrombotic thrombocytopenic purpura
Flora Peyvandi (Milano, Italy)
New generation concentrates for hemophilia and inherited bleeding disorders
Augusto B. Federici (Milano, Italy)
Rational use of fibrinogen concentrates
Marco Marietta (Modena, Italy)
Armando D’Angelo (Milano, Italy)
SATURDAY (27.5.2017)
9.30 - 13:30
Basic and Clinical III
Chairmen and Discussants: Alireza Rezaie (Oklahoma City, USA), Cesare Manotti (Parma, Italy)
Anticoagulation and fibrinolysis
Mario Colucci (Bari, Italy)
Polyphosphate and nucleic acids as triggers of blood clotting
Jim Morrissey (Urbana, USA)
Role of microparticles in inherited deficiencies of natural anticoagulants
Paolo Simioni (Padova, Italy)
Manuel Monreal (Barcelona, Spain)
Daniela Poli (Firenze, Italy)
